Own skin cells turned brain cells: a new hope for Parkinson's?
NCT ID NCT06687837
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This early-stage trial tests if transplanting a patient's own stem cells into the brain is safe for Parkinson's disease. Researchers take skin cells, turn them into dopamine-producing brain cells, and surgically place them in the brain. Only 8 people with moderate Parkinson's will join to check for side effects and see if movement improves.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PARKINSON DISEASE are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Massachusetts General Hospital
RECRUITINGBoston, Massachusetts, 02114, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Planning ahead: could a simple program transform Parkinson's care?
- Sound waves vs. Parkinson's: can ultrasound calm tremors and stiffness?
- Can a nudge in your chart unlock Life-Saving genetic clues?
- Can MRI reveal the Brain's response to deep brain stimulation?
- Can we outsmart Gaucher's hidden toll on lungs, bones, and brain?
- Could a brain disease change behavior years before diagnosis?